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EcdysisPeptide hormones governing many developmental processes are generated via endoproteolysis of inactive
precursor molecules by a family of subtilisin-like proprotein convertases (SPCs). We previously identiﬁed
mutations in the Drosophila amontillado (amon) gene, a homolog of the vertebrate neuroendocrine-speciﬁc
Prohormone Convertase 2 (PC2) gene, and showed that amon is required during embryogenesis, early larval
development, and larval molting. Here, we deﬁne amon requirements during later developmental stages
using a conditional rescue system and ﬁnd that amon is required during pupal development for head
eversion, leg and wing disc extension, and abdominal differentiation. Immuno-localization experiments
show that amon protein is expressed in a subset of central nervous system cells but does not co-localize with
peptide hormones known to elicit molting behavior, suggesting the involvement of novel regulatory peptides
in this process. The amon protein is expressed in neuronal cells that innervate the corpus allatum and
corpora cardiaca of the ring gland, an endocrine organ which is the release site for many key hormonal
signals. Expression of amon in a subset of these cell types using the GAL4/UAS system in an amon mutant
background partially rescues larval molting and growth. Our results show that amon is required for pupal
development and identify a subset of neuronal cell types in which amon function is sufﬁcient to rescue
developmental progression and growth defects shown by amon mutants. The results are consistent with a
model that the amon protein acts to proteolytically process a diverse suite of peptide hormones that
coordinate larval and pupal growth and development.© 2009 Elsevier Inc. All rights reserved.Introduction
Many peptide hormones and neuropeptides are produced by
limited proteolysis of inactive precursor peptides. The release of an
active peptide hormone from its precursor molecule typically occurs
by proteolytic cleavage after paired basic amino acids and is mediated
by a family of proteases known as the subtilisin-like proprotein
convertases (SPCs) (Bergeron et al., 2000). Following convertase
processing, most peptides undergo removal of the C-terminal basic
residues via a carboxypeptidase (Fricker and Leiter, 1999) and
subsequent α-amidation of the C-terminal glycine residue (Kulathila
et al., 1999). Processing of precursor proteins may liberate a single or
multiple bioactive products (Sossin et al., 1989; Zhou et al., 1999), and
a given precursor may be differentially processed in a cell-speciﬁc
fashion depending on the SPC processing enzymes expressed (Furuta
et al., 1997; Rouille et al., 1995). Thus processing of peptide hormone
precursors may serve as an important regulatory step to modulate
peptide and neuropeptide signaling.
Prohormone Convertase 2 (PC2) is one of seven vertebrate SPCs
identiﬁed to date and displays a neuroendocrine expression patternl rights reserved.that implicates the enzyme in the activation of peptide hormones and
neuropeptides (Muller and Lindberg, 2000). The Drosophila PC2
homolog, amontillado (amon), was identiﬁed based on sequence
similarity to conserved regions between yeast Kex2, human furin, and
human PC2 (Siekhaus and Fuller, 1999). amon is expressed throughout
the life cycle of the ﬂy, and amon transcripts localize to the larval
central nervous system and regions of the gut (Siekhaus, 1997;
Siekhaus and Fuller, 1999), suggesting that amon acts in neuroendo-
crine tissues. The amon protein has been shown to be an active
protease on a KR containing synthetic peptide when expressed in
Drosophila S2 cells with the Drosophila 7B2 protein, a homolog of the
7B2 protein that functions in maturation of vertebrate PC2 (Hwang et
al., 2000). Isolation and analysis of a series of EMS induced amon
mutants showed that amon is required during embryogenesis and
early larval development and suggests that the amon protein may act
to process peptide hormones that control hatching, larval growth, and
larval molting (Rayburn et al., 2003).
The regulation of molting and metamorphosis in insects has its
roots in an endocrine axis and relies on a delicate interplay between
steroid and peptide hormones (Ewer, 2005; Mesce and Fahrbach,
2002; Nijhout, 1994; Riddiford, 1993; Truman, 1992; Zitnan et al.,
2007). This axis includes the brain, the corpus allatum (CA), and the
prothoracic gland which act as sources of peptide and steroid
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steroid hormone 20-hydroxyecdysone, hereafter referred to as
ecdysone, act to initiate larval molting (Riddiford, 1993). One manner
in which ecdysone may exert its regulatory effect on molting and
metamorphosis is by affecting the expression of genes whose products
are part of the ecdysis cascade. For example, in both Manduca and
Drosophila the peptide hormone gene ecdysis triggering hormone
(eth) contains a putative ecdysone response element upstream of the
transcription start site (Park et al., 1999; Zitnan et al., 1999). Studies in
Manduca show that rising ecdysteroid levels prior to ecdysis induce
eth gene expression in the Inka cells and that a drop in the ecdysteroid
titer is required for ETH release (Zitnan et al., 1999).
Two additional peptide hormones, eclosion hormone (EH) and
crustacean cardioactive peptide (CCAP) are known to interact with
ETH in an ecdysis cascade to elicit the behavioral outputs that
characterize molting and metamorphosis in insects. Low levels of
circulating ETH trigger the release of EH from the brain. This initial EH
release induces a subsequent and exhaustive release of ETH from the
Inka cells which in turn cues exhaustive release of EH (McNabb et al.,
1997). In Manduca, EH acts through a second messenger system to
cause elevated levels of cGMP in cells that express CCAP (Ewer et al.,
1997). CCAP release elicits ecdysis motor burst while suppressing the
pre-ecdysis behaviors initiated by EH (Gammie and Truman, 1997).
Notably, the ETH and CCAP pro-peptides of Drosophila contain
putative dibasic processing sites (Park et al., 1999, 2003) suggesting
they require endoproteolytic activation. The Drosophila EH pro-
peptide also contains a possible dibasic processing site (Horodyski
et al., 1993), although processing at this site may not be necessary for
production of the bioactive EH peptide.
Here we have used a conditional rescue system to ask whether
amon is required during postembryonic developmental transitions
in Drosophila. amon mutants rescued past earlier embryonic and
larval requirements by heat-shock induced expression of an amon
cDNA and then removed from the rescue regime at the late third instar
stage display defects in head eversion, leg and wing extension, and
abdominal differentiation, indicating that amon activity is required for
these aspects of metamorphosis. Although amon mutants show
similar phenotypes to eth mutants and to pupae resulting from
CCAP-cell ablation, the amon protein does not co-localize with ETH,
CCAP, or EH, suggesting the existence of novel peptide hormones that
regulate molting and metamorphosis. Interestingly, the amon protein
localizes to cells that innervate the CA and corpora cardiaca (CC)
sections of the ring gland, suggesting that amon protein may regulate
the endocrine activity of this gland. Finally, expression of amon in a
subset of neuronal cell types in an amon mutant background is
sufﬁcient to partially rescue developmental progression and growth.
Materials and methods
Conditional rescue of amon mutants
One hundred ﬁfty yw; hs-amon/hs-amon; Df(3R)Tl-X e/TM3 Sb
Ser y+ e virgin females were crossed to 150 yw; amonC241Y or
amonQ178st e/TM3 Sb Ser y+ e males in an egg collection chamber
and allowed to lay eggs on 100 mm grape juice agar plates spotted
with yeast paste for 3 days at 25 °C. On the third day, a 4 or 8 h egg
collection was taken and yellow larvae (yw; hs-amon/+; amonC241Y
or amonQ178st e/Df(3R)Tl-X e) were collected at 36 h after egg laying
(ael) and placed on a fresh plate. Animals were heat shocked for
30 min at 37 °C every 24 h beginning at 36 h ael and subsequently
scored for survival until all the animals on the positive control plate
eclosed. Experimental animals were heat shocked as above until
108 h ael. After each scoring, larvae were transferred to a fresh plate
unless the animal had pupariated. Dead larvae were mounted in
polyvinyl lactophenol for examination. Pupae from the experimental
plate were removed from the pupal case in water under a Leitzdissecting scope once a majority of the control animals had
successfully eclosed. Once out of the pupal case, animals were
photographed using a digital camera (Hamamatsu 3CCD) mounted
to a Leitz dissecting scope. Control animals failing to eclose were
also removed from the pupal case and photographed at later time
points. Percent pupariated and eclosed values were calculated by
dividing the number of animals that had pupariated or eclosed by
the number of animals collected at 36 h ael.
Antibody development
A peptide corresponding to the ﬁnal 27 amino acids of the amon
protein with three additional amino terminal residues (CKC) was
synthesized by the Molecular Genetics Instrumentation Facility
(MGIF) at the University of Georgia. The peptide was coupled via M-
Maleimidobenzoyl N-Hydroxysuccinimide Ester (MBS, Pierce) to
bovine serum albumin as described below and then injected into
ﬁve mice at the Monoclonal Antibody Facility at the University of
Georgia. Following an initial subcutaneous injection with Freund's
complete adjuvant (Sigma Chemical), mice were boosted intraper-
itoneally using Freund's incomplete adjuvant every 21 days and bleeds
were taken approximately 7 days after each boost. Beginning with the
third bleed, serum was tested via Western analysis for its ability to
recognize the amon protein. Following the sixth boost one mouse
produced serum speciﬁc for amon protein and was subsequently
boosted a total of 15 times over the course of about 1 year. Bleeds
taken after the seventh boost were used in the immunocytochemistry
and Western analyses as described below.
Antigen generation
Five milligrams of carrier protein (Bovine Serum Albumin, Sigma)
was dissolved in 1mL of phosphate buffered saline (PBS). 50 μL of MBS
in N, N dimethylformamide (DMF) was added drop by drop to 500 μL
of the carrier protein solution and then stirred at room temperature
for 30 min. Excess MBS was removed using Micro Bio-Spin P-30 Tris
Chromatography Columns (Bio-Rad) equilibrated with PBS. A 20-fold
excess of synthetic peptide was added to the carrier protein–MBS
solution and stirred at room temperature for 3 h. To make sure that
peptide was coupled to the carrier protein, the solution was run on a
10% polyacrylamide gel next to a control solution (carrier protein–
MBS solution alone) and stained with Coomassie.
Immunocytochemistry
Wandering third instar larvae (Canton S) were dissected, ﬁxed (2 h
in PBS and 175 mM NaCl, pH 7.4, with 4% paraformaldehyde),
dehydrated, and rehydrated according to the protocol of Cao and
Brown (2001). Tissues werewashed in TBS (25mMTris, 137mMNaCl,
0.27mMKCl) containing 0.5% Triton X-100 (TBST) two times for 5min
each and then blocked in TBST+ 5% goat serum overnight at 4 °C. All
subsequent steps were performed at 4 °C. Primary antiserum was
added in TBST+ 2% BSA at a 1/200 dilution and left overnight.
Following a wash of at least 1 h in TBST+ 2% BSA, the secondary
antibody (anti-mouse IgG conjugated to Alexa Fluor 488, 568 or 594,
Molecular Probes, Inc.) was added at a dilution of 1:500–1:2000 in
TBST+ 2% BSA and tissues were incubated overnight in the dark.
Tissues underwent a ﬁnal wash in TBST and were then mounted on
slides in a 1:1 TBST/glycerol solution. Images were captured on an
Olympus BX60 microscope using a JVC digital camera (model
KYF70BM) and the AutoMontage (Syncroscopy) software. To obtain
amon mutant third instar CNS tissues for use as a control, amon
mutant larvae (yw; hs-amon/+; amonQ178st e /Df(3R)Tl-X e) were
rescued past early developmental requirements for amon function by
periodic expression of a hs-amon transgene for 45 min at 37 °C every
24 h, beginning at 36 h AEL until 84 h AEL. The CNS was dissected at
Table 1
amon is required for eclosion.
Genotype Treatment % Eclosed
yw; hs-amon/+;amonC241Y/Tl-X Control 42 (n=50)
yw; hs-amon/+;amonC241Y/Tl-X Experimental 1 (n=71)
yw; hs-amon/+;amonQ178st/Tl-X Control 60 (n=15)
yw; hs-amon/+;amonQ178st/Tl-X Experimental 0 (n=22)
amon mutant hemizygotes, recognizable by the yellow marker, were collected at 36 h
ael and were heat shocked every 24 h until all animals eclosed (control) or until the late
third instar stage (experimental). n equals the number of mutant hemizygotes collected
at 36 h ael and % eclosed equals the number of animals eclosed/n. Tl-X, Df(3R)Tl-X, is a
deﬁciency that removes amon (Rayburn et al., 2003).
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mutants and control siblings (yw; hs-amon/+; Df(3R)Tl-X e or
amonQ178st e/TM3 Sb Ser y+ e).
For co-localization of amon and ETH, the same protocol was
followed except that after blocking, tissues were incubated with the
mouse antiserum directed against the amon peptide for 3 h, washed
for 1 to 2 h, incubated in the anti-mouse secondary antibody for 3 h,
and washed overnight. The next day, the same procedure was
followed for a rabbit antiserum directed against ETH (Park et al.,
2002) used at a 1:500 dilution and a secondary antibody (anti-rabbit
IgG conjugated to Alexa Fluor 568, Molecular Probes, Inc.) used at a
1:500 dilution. Alternatively, tissues were incubated in the mouse
anti-amon antiserum for 3 h, washed for 1 to 2 h, incubated in the
rabbit anti-ETH antiserum for 3 h, washed for 1 to 2 h, and then
incubated in both mouse and rabbit secondary antibodies overnight.
The following day, tissues were washed for 3 h in TBST, mounted on
slides, and visualized.
For co-localization with tissues expressing GFP, the UAS-mCD8-
GFP line (Lee and Luo, 1999) was crossed to EH-GAL4 (McNabb et al.,
1997), Kurs-21, (Siegmund and Korge, 2001), and CCAP-GAL4 (Park et
al., 2003) to obtain progeny with GFP in the EH neurons, the CA-
innervating neurons, and the CCAP neurons respectively. Wandering
third instar larvae were dissected and then processed as described
above for amon protein detection.
Western analysis
Animals were homogenized in cracking buffer (0.125 M Tris–HCl,
pH 6.7, 5% β-mercaptoethanol, 2% sodium dodecyl sulfate, 4 M urea)
(10 μL per adult ﬂy, 5 μL per third instar larvae) containing a Complete
Mini EDTA-free protease inhibitor cocktail tablet (Roche) using
motorized hand held pellet pestles (Konte) for 1.5 mL eppendorf
tubes. Protein homogenates were boiled for 5 min and centrifuged for
10min at 14,000 ×g using a benchtopmicrofuge. The supernatant was
boiled for 5 min in an equal volume of sample buffer (0.125 M Tris–
HCl, pH 6.8, 1% sodium dodecyl sulfate, 20% glycerol, and 0.02%
bromophenol blue) and then loaded onto a 10% polyacrylamide gel.
Proteins were transferred to a nitrocellulose membrane (Schlie-
cher and Schuell BioScience, Inc) overnight in a Bio-Rad Transfer Cell
and the membrane was blocked in blocking solution (10% non-fat dry
milk, 30% goat serum) in TBS/Tween (20 mM Tris–HC1, pH 7.5,
500 mM NaCl, 0.05% Tween20) overnight at −20 °C. Primary
antiserum was added at a 1:2000 dilution in blocking solution and
incubated at room temperature for 2 to 3 h. After three washes of at
least 5 min each, a horseradish peroxidase conjugated secondary
antibody (anti-mouse IgG-HRP, Promega) was added at a 1:1500
dilution and incubated for 30 min at room temperature. Following
three more washes of at least 5 min each, peroxidase activity was
detected using Lumi-Light Western Blotting Substrate (Roche). Excess
substrate solution was blotted off the membrane and then images
were captured using Kodak BioMax Light ﬁlm.
For the developmental Western analysis, a 4 h Canton-S egg
collection was taken at 25 °C and animals were aged to the following
time points after the end of egg laying (ael): 16 h, 20 h, 40 h, 64 h, 84 h,
and 96 h. In our hands these time points correspond to embryogenesis
(16 and 20 h ael), ﬁrst instar, second instar, early third instar, andmid-
third (non-wandering) instar, respectively. For the wandering third
instar and white pre-pupal time points, animals were collected at the
appropriate developmental stage. Animals were homogenized as
described above in the following amounts of cracking buffer: 0.25 μL
per ﬁrst or second instar animal, 3 μL per early third instar animal, 5 μL
per mid and wandering third instar animal, and 10 μL per white pre-
pupa.
For antibody blocking experiments, approximately 100 μg of the C-
terminal amon peptide used for injection into mice, or one of two
control peptides corresponding to EcR-B1 or EH, was added to theantiserum in 1mLof blocking solution and then allowed to incubate for
30min at room temperature. The consequences of pre-absorptionwith
amon or control peptides were then tested using a Western blot as an
assay.
Rescue of amon mutant defects
To determine if amon function in speciﬁc neuronal cell types is
sufﬁcient to rescue amon mutant defects, approximately 150 yw; uas-
amon40L; Tl-X e/TM3 Sb Ser y+ e virgin females and 150 yw; +; Kurs21-
gal4, amonC241Ye/TM3 Sb Ser y+ emalesweremated in an egg collection
chamber containing a grape juice agar plate with fresh yeast paste at
25 °C. As a control cross, 150 yw; uas-amon40L; Tl-X e/TM3 Sb Ser y+ e
virgin females and 150 yw; +; amonC241Y/TM3 Sb Ser y+ e males were
mated in the same way. A 4 h egg collection on grape juice agar plates
with yeast paste was taken 24 h later. At 36 h ael amon mutant larvae,
recognizable by the yellowmarker, (yw; uas-amon40L/+; Tl-X e/Kurs21-
gal4, amonC241Y e) andwild-type control larvae (yw; uas-amon40L/+; Tl-
X e or amonC241Y e/TM3 Sb Ser y+ e) were selected and moved to fresh
grape juice agar plates with yeast paste. Larvae were scored every 24 h
based on spiracle morphology to determine whether they were ﬁrst,
second, or third instar larvae.
Results
amon is required during pupal development
amon mutants arrest during embryogenesis and early larval
development (Rayburn et al., 2003). To determine the requirements
for amon during later development, we have rescued amon mutants
by periodic heat induced expression of an amon cDNA. In Table 1, we
show that continuous daily expression of amon (see Materials and
methods) starting at 36 h after egg laying (ael) rescues two amon
mutant hemizygotes, amonC241Y and amonQ178st, to adulthood. In
contrast, removal of heat-shock treatment at the late third instar stage
(108 h ael) results in a failure to eclose.
As shown in Figs. 1C–F, the predominant phenotype of the arrested
amonC241Y animals was a failure to evert the head coupled with a
failure to extend the legs and wings (91%, Table 2). This phenotype
also predominated in arrested amonQ178st animals (33%, Table 2).
Interestingly, the failures in head eversion and leg and wing extension
did not preclude further development of these structures as evidenced
by tanning and bristle formation (Figs. 1C,D), nor did they prevent the
differentiation and pigmentation of the eye (data not shown). Because
events such as bristle formation on the legs and eye pigmentation
typically occur after a successful head eversion (Bainbridge and
Bownes, 1981), the phenotypes of the amonmutant pupae indicate an
uncoupling of the early event of head eversion and the events
characteristic of late stages of pupal development.
A smaller proportion of amon mutants displayed failures in
abdominal differentiation (Figs. 1C,D, Table 2). For example, 58% of
the amonC241Y animals and 27% of the amonQ178st did not complete
abdominal differentiation. The undifferentiated abdomens resembled
Fig. 1. amon is required during pupal development. Dorsal (A) and ventral (B) views of a wild-type (Canton S) stage P13 pupa showing completion of head eversion, leg and wing
extension (arrows), and abdominal differentiation. Dorsal (C) and ventral (D) views of an amonmutant (yw; hs-amon/+; amonC241Y/Df(3R)Tl-X) rescued by amon expression during
larval development. In this animal, head eversion is blocked and leg andwing extension is defective (arrows). In addition, abdominal differentiation has failed to take place (asterisk).
Dorsal (E) and ventral (F) views of a second amonmutant (yw; hs-amon/+; amonC241Y/Df(3R)Tl-X) rescued by amon expression during larval development. Arrows indicate the gas
bubble that has failed to translocate to the posterior end of the puparium during metamorphosis.
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transparent and lack segmentation and bristles. The failure in
abdominal differentiation did not, however, prevent the thoracic
segment from acquiring pigment and bristles, indicating that these
two body segments are governed by distinct developmental controls.
An additional phenotype displayed by 15% of the amonC241Y mutants
was a failure to displace the pre-pupal gas bubble, an event that
typically marks the transition from the P2 to the P4 stage of
development (Bainbridge and Bownes, 1981) (Figs. 1E,F, Table 2).
Interestingly, all of the pupae failing to displace the mid-body gas
bubble developed bristled abdomens, a characteristic of a much later
developmental stage (P12i) (Bainbridge and Bownes, 1981). Collec-
tively, our results show that amon is required for successful
coordination and completion of pre-pupal and pupal development.
The amon protein is expressed during pupal stages
To determine the localization pattern of the amon protein, we
developed a mouse polyclonal antibody against the amon protein and
used it in Western and immunocytochemistry experiments to
evaluate the presence and localization of the protein. On Western
blots, the polyclonal antiserum recognizes a 97 kDa band that is
present in all developmental stages examined (Fig. 2). The levels of
the 97 kDa protein increase in abundance over developmental time in
accordance with RNA expression data reported earlier for amon
(Siekhaus and Fuller, 1999). This pattern of expression is consistent
with the requirements we have uncovered for amon during larval and
pupal life (Rayburn et al., 2003 and this paper). Recognition of the
97 kDa band on Western blots is reproducibly abolished in blocking
experiments (see Materials and methods) in which the amon
polyclonal antiserum is pre-incubated with the amon peptide antigen
but not abolished when control peptides corresponding to EcR-B1 or
EH are used (data not shown). Recognition of a second 66 kDa bandTable 2
Phenotypes of amon mutant pupae.
Phenotype amonC241Y (n=33) amonQ178st (n=22)
Failure to evert head 91 33
Failure to extend legs and wings 91 33
Undifferentiated abdominal cuticle 58 27
Gas bubble not displaced 15 0
Failure to evert the head and to extend the thoracic appendages is the predominant
phenotype observed in amon mutant hemizygotes (amon/Df(3R)Tl-X). Additional
phenotypes observed include failures in abdominal differentiation and mid-body gas
bubble displacement.seen at some developmental stages (Fig. 2) is not blocked by pre-
incubationwith the amon peptide. The 66 kDa protein thus appears to
be antigenically unrelated to amon.
In tissue stains (Figs. 3A,B), we ﬁnd that the amon antiserum
recognizes cells within the central nervous system (CNS) of wild-type
third instar larvae but that no signal is seen in this tissue in amon
mutant third instar larvae (see Materials and methods). The
localization pattern in the larval CNS consistently includes paired
ventral nerve cord cells as well as a pair of brain cells known as the
medial neurosecretory cells (MNCs) (Cao and Brown, 2001; Rulifson
et al., 2002) or the insulin producing cells (IPCs) (Rulifson et al.,
2002). We report elsewhere that the amon protein co-localizes with
DILP2 in these cells (Rhea, Rayburn and Bender, in preparation). The
amon antiserum also recognizes cells within the midgut of wild-
type third instar larvae. These cells include endocrine cells within
thicker portions of the gut, a pattern consistent with in situ
hybridization experiments using amon nucleic acid probes (Siekhaus,
1997). Midgut endocrine cells have been identiﬁed in a variety of
insect species and are hypothesized to act as monitors of the presence
or absence of food in the gut, releasing their peptide hormone
contents to direct foodmovement and digestion (Brown, 2003; Brown
and Lea, 1989).
Candidate targets of the amon protein
The homology of amon to proprotein convertase genes and the
phenotypes of amon mutant larvae and pupae suggest that peptide
hormones governing larval molting, larval growth, head eversion, leg
and wing extension and abdominal differentiation are potentialFig. 2. Developmental expression of the amon protein. The anti-AMON antiserum
detects a 97 kDa band that is present inwild-type (Canton S) animals during all stages of
embryogenesis, larval development, and pupal development tested. Approximately
equivalent amounts of protein were loaded in each lane (see Materials and methods)
from the following stages of development: 16 to 20 (E20) and 20 to 24 (E24) hour old
embryos, the ﬁrst (L1) and second (L2) instar larval stages, early (eL3), mid (mL3), and
wandering (wL3) third instar stages and pupal stages beginning at pupariation (time 0)
and continuing through pupal development 48 h after pupariation (48). The 66 kDa
band indicated here appears to be antigenically unrelated to the amon protein (see the
Results and Materials and methods sections).
Fig. 3. The amon protein localizes to the central nervous system and larval midgut endocrine cells. (A) Third instar larval CNS labeled for amon protein (20×magniﬁcation). The large
arrowheads indicate amon protein localization to the MNCs. Small arrows indicate prominent ventral nerve cord cells. (B) amon mutant third instar larval CNS shows a lack of
staining using the amon antiserum (20×). (C) Third instar larval gut labeled for the amon protein. The protein localizes to the midgut endocrine cells (inset) in the thicker regions of
the midgut. Panel C (10×) shows the anterior portion of the midgut behind the proventriculus. Panel D (20×) shows a more posterior portion of the midgut located near the midgut–
hindgut junction. Dashed box in C indicates area magniﬁed in inset.
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looked for co-localization of amon protein and candidate peptide
hormone targets in the CNS.
The timing and behavioral events of larval molting are controlled
by the peptide hormones eclosion hormone (EH), ecdysis triggering
hormone (ETH), and crustacean cardioactive peptide (CCAP) (Mesce
and Fahrbach, 2002). The localization of these three peptide
hormones in Drosophila have been established (Horodyski et al.,
1993; Park et al., 2002, 2003), and both ETH and CCAP containFig. 4. The amon protein does not co-localize with ETH or EH. (A) Third instar larval trachea la
Inka cell. (B) The same trachea labeled using an antiserum directed against the amon protei
(McNabb et al., 1997) and a UAS-mCD8-GFP reporter (Lee and Luo, 1999). (E) The same CNpotential dibasic processing sites (Park et al., 2002, 2003). In other
insects, mature bioactive EH appears to be produced directly
following cleavage of the signal sequence by signal peptidase
(Horodyski et al., 1989; Wei et al., 2008; Zhang and Xu, 2006).
The Drosophila EH pro-peptide includes a dibasic KR motif located 9
amino acids after the putative signal peptidase cleavage site
(Horodyski et al., 1993). However, it has not been demonstrated
that this potential processing site is used or is necessary for
production of the mature bioactive Drosophila EH peptide. We usedbeled using an antibody directed against ETH (Park et al., 2002). The arrow indicates the
n. (C) Merged image (40×). (D) Third instar CNS of a larva carrying an EH-GAL4 driver
S as in (D) labeled for amon protein. (F) Merged image.
Fig. 5. The amon protein localizes to CA and CC-innervating neurons. (A) Third instar CNS of a larva carrying the Kurs-21 GAL4 driver (Siegmund and Korge, 2001) and the UAS-
mCD8-GFP reporter (Lee and Luo, 1999). GFP signal is seen in the CA-LP1 (arrowhead), the CA-LP2 (arrow), and CC-MS2 (box) neurons. (B) A separate third instar CNS carrying the
Kurs-21 GAL4 driver and the UAS-mCD8-GFP driver. (C) The same CNS as in (B) labeled with antiserum against the amon protein. (D) Merged image of (B) and (C). (E). Third instar
CNS larva carrying the Kurs-21 GAL4 driver and the UAS-mCD8-GFP driver. GFP signal is seen in the CC-MS2 cells. (F). The same CNS as is (E) labeled for the amon protein. (G) Merged
image of (E) and (F).
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and GFP reporters to identify ETH, EH, or CCAP-expressing cells in
the brains of wild-type larvae. We then asked whether the amon
protein was co-expressed in these cells (Fig. 4). As seen in Figs. 4A–
C, the amon protein and ETH do not co-localize to the epitracheal
Inka cell. Similarly, amon protein does not co-localize with EH in the
two ventromedial EH neurons (Figs. 4D–F), nor does it localize to
the CCAP-expressing cells (data not shown). Our results with ETH
and CCAP conﬁrm the previous study of Park et al. (2004) and
together, these results suggest that ETH, EH, and CCAP are not direct
substrates of the amon protein.Fig. 6. amon expression in cells deﬁned by the Kurs-21 GAL4 driver of an amon mutant is s
Percent survival to the second instar larval stage is shown for amonmutants (yw; hs-amon/+
(3R)Tl-X e or kurs 21-gal4, amonC241Y/TM3 Sb Ser y+ e, black bar), and rescued amon mutant
animals per genotype. In addition to increased survival, rescued amon mutants show an int
larvae are shown.The lack of abdominal differentiation in both amonC241Y and
amonQ178st mutant pupae (Figs. 1C,D, Table 2) resembles that seen in
late third instar larvae and pre-pupae treated with excess amounts of
the terpenoid juvenile hormone (JH) and its mimics (Ashburner,1970;
Madhavan, 1973; Zhou and Riddiford, 2002). Because the release of JH
from the corpus allatum (CA) is inhibited by the peptide hormone
allatostatin (Nijhout, 1994), animals treated with excess JH and
animals lacking an active allatostatin peptide hormone could be
predicted to display similar phenotypes. Recently Siegmund and
Korge (2001) identiﬁed a GAL4 driver that strongly identiﬁes three
neurons innervating the CA, and is weakly expressed the VM andufﬁcient to partially rescue the molting and growth defect seen in amon mutants. (A)
; Df(3R)Tl-X e/kurs-gal4, amonC241Y, white bar), their control siblings (yw; hs-amon; Df
s (yw; hs-amon/uas-amon; Df(3R)Tl-X e/kurs 21-gal4, amonC241Y, hatched bar). N=100
ermediate size (D) between control siblings (B) and amon mutants (C). Representative
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synapses on the CA using synapse-speciﬁc antibodies, Siegmund and
Korge argue that these are the only neurons in Drosophila that form
synapses on the CA (Siegmund and Korge, 2001) making them
candidates for allatostatin expression. We used the Kurs-21 driver
(Fig. 5A) and a GFP reporter to identify these neurons and then
examined them for amon protein localization.
Figs. 5B–D show that the amon protein localizes to the three CA-
innervating cells, CA-LP1 and CA-LP2. In addition, the amon protein
localizes to two cells also identiﬁed by the Kurs-21 GAL4 driver known
as CC-MS2 (Figs. 5E–G) which innervate the corpora cardiaca (CC)
portion of the ring gland. It is therefore tempting to speculate that
amon activity in cell types that innervate the CA and CC may inﬂuence
the regulatory activities of these two important endocrine signaling
centers.
To examine the functional consequences of restoring amon
expression in the CA-LP1 and CA-LP2 cells in an amon mutant
background, we expressed a uas-amon construct in these cells using
the Kurs-21 GAL4 driver. Fig. 6A shows that amon function in these
cells is sufﬁcient to partially rescue developmental progression. Only
14% of ﬁrst instar amon mutant larvae successfully complete the ﬁrst
to second instar larval molt and emerge as second instar larvae. In
contrast, when amon function is restored in the CA- and CC-
innervating neurons in an amon mutant background, 64% of amon
mutant larvae complete this molt and emerge as second instar larvae
(Fig. 6A). Restoring amon expression to the CA- and CC-innervating
cells is also sufﬁcient to partially rescue growth in amon mutants
(Figs. 6B–D). Rescued amon mutant larvae (Fig. 6D) are intermediate
in size compared to amon mutant (Fig. 6C) and control sibling larvae
(Fig. 6B). Thus, restoring amon function in the cells deﬁned by the
Kurs-21 GAL4 enhancer trap line is sufﬁcient to partially rescue the
molting and growth defects exhibited by amon mutants.
Discussion
amon is required for pupal development
Analysis of loss of function amon mutations has shown that amon
is required during early larval development and for the completion of
the ﬁrst to second instar larval molt (Rayburn et al., 2003). Here we
have used a conditional rescue system to show that amon is also
required for successful completion of pupal development and eclosion
of the adult ﬂy (Table 1). The predominant phenotypes of two amon
mutant alleles in which amon expression was removed at the late
third instar larval stage indicate a requirement for amon for behavioral
events characterizing early stages of pupal development (Fig. 1, Table
2) and suggest that the developmental events of metamorphosis can
be uncoupled.
The arrested amon mutant pupae fail to undergo head eversion
(Fig. 1), an event that occurs in wild-type animals at 12–14 h after
pupariation (Bainbridge and Bownes, 1981), yet they complete
processes such as eye pigmentation and head bristle formation
(data not shown) that typically take place only after successful head
eversion. Interestingly, despite the failure to complete head eversion
and leg and wing extension, two of the earliest events of pupal
development, the thoracic segment of these animals appears to
develop normally as evidenced by its pigmentation and bristle
formation (Fig. 1). Similarly, in a majority of the amonC241Y mutant
pupae (58%) and a signiﬁcant percentage of the amonQ178st mutant
pupae (27%), the abdominal segment fails to differentiate despite the
developmental progression of the anterior segments (Table 2, Fig. 1).
In addition, a small subset of arrested amonC241Y pupae (15%) fail to
anteriorly displace the mid-body gas bubble, an event that typically
happens prior to head eversion, yet they display abdominal
differentiation. These observations suggest that the head, thoracic,
and abdominal segments of the ﬂy respond to endocrine cuesindependently of one another and that interruption of these signals
can cause an uncoordinated pattern of metamorphosis.
The amon protein localizes to the nervous system but does not co-
localize with known neuropeptides governing molting and
metamorphosis
The amon protein localizes to cells in the central nervous system
and gut in third instar animals (Fig. 3). To identify potential amon
protein substrates, we compared the localization of three neuropep-
tides involved in molting and metamorphosis, CCAP, ETH, and EH
(Park et al., 2003; Ewer et al., 1997; McNabb et al., 1997; Park et al.,
2002) to that of the amon protein. Phenotypic similarities between
amon and ETH mutants (Park et al., 2002) and amon mutant pupae
and pupae lacking the CCAP neurons (Park et al., 2003) suggested a
relationship between amon and these peptide hormones. However,
the amon protein does not co-localize with CCAP (data not shown),
ETH, or EH (Fig. 4) arguing against a direct enzyme–substrate
relationship between the amon protein and these neuropeptides. It
is interesting to note, however, that amon transcripts were detected in
the Inka cells by Siekhaus and Fuller (1999), but that another group
(Park et al., 2004) using a different antiserum against the amon
protein (Hwang et al., 2000) have also determined that the amon
protein does not localize to the Inka cells, suggesting possible post-
transcriptional regulation of the amon mRNA. This same group also
examined amon protein's localization in relation to the CCAP-
expressing cells and observed the same lack of co-localization we
report here (Park et al., 2004). Together, these results suggest that
additional, as yet unidentiﬁed peptide hormones are involved in the
regulation of larval molting and metamorphosis. Such a conclusion is
supported by a study of the relationship among EH, ETH, and CCAP
which suggests that exogenous ETH's ability to elicit pre-ecdysis
requires the EH cells and that EH may act independently of CCAP to
elicit ecdysis (Clark et al., 2004).
Western analysis shows that the amon protein is present in all
stages of development (Fig. 2). We note that the band recognized by
our antiserum onWestern blots does not migratewith a size similar to
that reported for the amon protein in a previous study in which two
bands migrating at 80 and 75 kDawere detected from extracts of third
instar larvae and the medium of S2 cells expressing amon and d7B2
(Hwang et al., 2000). We cannot currently explain the apparent size
differences between these studies but note that the 97 kDa band
detected here is competed by addition of amon peptides and not by a
non-speciﬁc peptide competitor and that heat-shock induced expres-
sion of an amon cDNA leads to leads to increases in abundance of the
97 kDa band (data not shown). It is possible that differences in the
apparent mobility of the amon protein result from differing poly-
acrylamide gel electrophoresis conditions in the two studies.
Identiﬁcation of cell-type speciﬁc requirements for amon
Although in vivo mutational studies are critical to understanding
the physiological roles played by SPCs (Furuta et al., 1997; Kass et al.,
2001; Rayburn et al., 2003), the fact that these proteases havemultiple
processing targets creates difﬁculties in interpretation of phenotypes
seen in mutants completely lacking function for a given SPC. Here we
have begun to dissect the signaling contribution of subsets of neuronal
cells to normal Drosophila development by restoring amon expression
to these cells in an amonmutant background. We ﬁnd that expression
of amon using the Kurs-21 GAL4 driver partially rescues larval growth
andmolting defects exhibited by amonmutants (Fig. 6). This result ties
amon function in cells deﬁned by the Kurs-21 GAL4 driver to the
regulation of larval molting and growth and suggests that the Kurs-21
cells may produce a processed peptide hormone signal that functions
in these pathways. Because subsets of Kurs-21 cells make synaptic
connections to either the CA or the CC, in the future it will be
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here acts via the CA or CC, or both, and whether this effect intersects
the known signaling pathways controlling ecdysis and growth.
Previous genetic analysis of the peptide hormone processing
enzyme PHM, which acts to α-amidate C-terminal residues of
secretory peptides, has shown the importance of secreted peptide
hormones in the modulation of developmental transitions and
highlighted the potential of genetic methods in dissecting the
contribution of secreted peptides to normal developmental progres-
sion (Jiang et al., 2000). The rescue approach that we describe here is a
ﬂexible genetic tool that can be used to correlate amon function in
speciﬁc neuronal cells with the control of normal aspects of
development and physiology as initially inferred from amon loss of
function genetic studies and to ask whether and how amon
contributes to the regulation of peptide hormone signaling. A
powerful complementary approach to determine cell types in which
amon function is required for normal growth and development will
be the reduction of amon function in speciﬁc neuronal cell types using
RNA inactivation. Numerous peptide hormones possessing potential
dibasic cleavage sites have been identiﬁed in Drosophila (Hewes and
Taghert, 2001). Ultimately, the genetic techniques described above
may identify cells in which these known peptide signals are used in
new ways and have the potential to lead to the identiﬁcation of novel
peptide signals.
The phenotypic and localization data presented here suggest that
the amon protein functions in a wide variety of neuroendocrine cell
types to process and activate a diverse suite of peptide hormones that
coordinate larval and pupal development. In the future, we hope to
identify cell types in which amon function is required for control of
speciﬁc physiological, behavioral, or developmental events through
cell-type speciﬁc rescue and inactivation experiments. A second
important challenge for the future is biochemical identiﬁcation of
direct proteolytic substrates of the amon protein.
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